L. Gooding

发表

Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis

C. Ware, T. Horton, T. Ranheim, 1991, Journal of virology.

A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact

L. Gooding, C. Perez, I. Albert, 1990, Cell.

Limited but durable changes to cellular gene expression in a model of latent adenovirus infection are reflected in childhood leukemic cell lines

L. Gooding, M. Dickherber, C. Garnett-Benson, 2016, Virology.

Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen.

L. Gooding, K. O'connell, 1983, Journal of immunology.

A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes

T. Horton, W. Wold, L. Gooding, 1990, Journal of virology.

T-cell responsiveness to an oncogenic peripheral protein and spontaneous autoimmunity in transgenic mice.

R. Flavell, L. Gooding, T. Geiger, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Induction of the heat shock response protects cells from lysis by tumor necrosis factor.

C. Ware, D. Kusher, L. Gooding, 1990, Journal of immunology.

Adenovirus DNA is detected at increased frequency in Guthrie cards from children who develop acute lymphoblastic leukaemia

A. Nordgren, L. Gooding, G. Bogdanovic, 2007, British Journal of Cancer.

Adenovirus DNA in Guthrie cards from children who develop acute lymphoblastic leukaemia (ALL)

L. Gooding, G. Bogdanovic, B. Gustafsson, 2010, British Journal of Cancer.

Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor

J. Lancaster, L. Gooding, S. Laster, 1989, FEBS letters.

Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype

J. Kaplan, L. Gooding, A. Smith, 1997, Journal of virology.

Macrophage-Mediated Cytotoxicity

P. Duerksen-Hughes, L. Gooding, 1993 .

Human Bocavirus in Tonsillar Lymphocytes

Xiaoyan Lu, L. Gooding, D. Erdman, 2008, Emerging infectious diseases.

Immunological identification of nascent subunits of wheat ribulose diphosphate carboxylase on ribosomes of both chloroplast and cytoplasmic origin.

A. Jagendorf, L. Gooding, H. Roy, 1973, Archives of biochemistry and biophysics.

The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells

P. Duerksen-Hughes, W. Wold, L. Gooding, 1991, Journal of virology.

A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor

L. Elmore, W. Wold, L. Gooding, 1988, Cell.

Three Adenovirus E3 Proteins Cooperate to Evade Apoptosis by Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor-1 and -2*

F. Martinon, J. Tschopp, C. Benedict, 2001, The Journal of Biological Chemistry.

Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes

R. Tripp, W. Wold, L. Gooding, 1993, Journal of virology.

Latent Species C Adenoviruses in Human Tonsil Tissues

L. Gooding, C. T. Garnett, G. Talekar, 2008, Journal of Virology.

The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.

P. Duerksen-Hughes, W. Wold, L. Gooding, 1990, Journal of immunology.

A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2.

S. K. Saha, W. Wold, L. Gooding, 1990, Virology.

Detection and quantitation of subgroup C adenovirus DNA in human tissue samples by real-time PCR.

L. Gooding, C. T. Garnett, C. Pao, 2007, Methods in molecular medicine.

Molecular mechanisms by which adenoviruses counteract antiviral immune defenses.

W. Wold, L. Gooding, 1990, Critical reviews in immunology.

Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor.

P. Duerksen-Hughes, W. Wold, L. Gooding, 1989, Journal of immunology.

Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1A is immunodominant in H-2b, but not in H-2d or H-2k mice.

R. Ricciardi, P. Duerksen-Hughes, W. Wold, 1991, Journal of immunology.

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.

P. A. Peterson, J. Kaplan, L. Gooding, 1997, Human gene therapy.

Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments.

L. Gooding, S. Laster, M. Scanlon, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Modeling Adenovirus Latency in Human Lymphocyte Cell Lines

L. Gooding, D. Ornelles, Yange Zhang, 2010, Journal of Virology.

Adenovirus DNA is detected at increased frequency in Guthrie cards from children who develop acute lymphoblastic leukaemia

A. Nordgren, L. Gooding, G. Bogdanovic, 2007, British Journal of Cancer.

Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.

L. Gooding, 1977, Journal of immunology.

Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk.

L. Gooding, 1982, Journal of Immunology.

The Adenovirus E3 RID Complex Protects Some Cultured Human T and B Lymphocytes from Fas-Induced Apoptosis

L. Gooding, C. T. Garnett, A. McNees, 2002, Journal of Virology.

The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha

E. White, P. Sabbatini, D. Kusher, 1992, Molecular and cellular biology.

Cloned cytotoxic T lymphocytes recognize cells expressing discrete fragments of the SV40 tumor antigen.

L. Gooding, K. O'connell, 1984, Journal of immunology.

Fine mapping of an H-2Kk restricted cytotoxic T lymphocyte epitope in SV40 T antigen by using in-frame deletion mutants and a synthetic peptide.

L. Gooding, K. O'connell, R. Geib, 1988, Journal of immunology.

A 14,500 MW protein is coded by region E3 of group C human adenoviruses.

W. Wold, L. Gooding, P. Krajcsi, 1990, Virology.

Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex.

L. Gooding, 1979, Journal of immunology.

Involvement of histocompatibility antigens in embryonic cell recognition events

D. McClay, L. Gooding, D. McClay, 1978, Nature.

Activation of intracellular proteases is an early event in TNF-induced apoptosis.

W. Wold, L. Gooding, S. Laster, 1995, Journal of immunology.

8 – Cytotoxic T Cell Recognition of the SV40 Tumor Antigen: A Note of Caution

J. Pipas, L. Gooding, O. apos, 1988 .

CELL SURFACE ANTIGENS OF A MOUSE TESTICULAR TERATOMA IDENTIFICATION OF AN ANTIGEN PHYSICALLY ASSOCIATED WITH /-/-g ANTIGENS ON TUMOR

M. Edidin, L. Gooding, 2003 .

Adenovirus Death Protein (ADP) Is Required for Lytic Infection of Human Lymphocytes

W. Wold, L. Gooding, C. Garnett-Benson, 2013, Journal of Virology.

Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.

W. Wold, L. Gooding, 1989, Molecular biology & medicine.

H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.

L. Gooding, C. Edwards, 1980, Journal of immunology.

Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells.

L. Gooding, 1979, Journal of immunology.

Virus proteins that counteract host immune defenses

L. Gooding, 1992, Cell.

Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions.

W. Wold, L. Gooding, L. R. Gooding, 1991, Virology.

Prevalence and Quantitation of Species C Adenovirus DNA in Human Mucosal Lymphocytes

L. Gooding, D. Erdman, C. T. Garnett, 2002, Journal of Virology.

The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis

C. Ware, C. Yang, L. Gooding, 1997, Journal of virology.

Expression of early fetal antigens on transformed mouse cells.

L. Gooding, 1976, Cancer research.

Expression of teratoma-associated antigens on murine ova and early embryos. Identification of two early differentiation markers.

M. Edidin, L. Gooding, Y. Hsu, 1976, Developmental biology.

Surface antigens of normal early embryos and a tumour model system useful for their further study.

M. Edidin, L. Gooding, M. Johnson, 1975, Acta endocrinologica. Supplementum.

Solubilization of complexes between tumor‐associated and H‐2 antigens from a tumor cell plasma membrane

L. Gooding, P. J. Honeycutt, Pamela J. Honeycutt, 1980, European journal of immunology.

Inhibition of glycosylation prevents H‐2K and D antigen expression on SV40 virus‐transformed cells

L. Gooding, S. Swaminathan, 1983, European journal of immunology.

Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

L. Gooding, S. Laster, J. G. Wood, 1988, Journal of immunology.

The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells

P. Duerksen-Hughes, T. Horton, L. Aquino, 1991, Journal of virology.

Adenoviral inhibitors of apoptotic cell death.

L. Gooding, A. McNees, Adrienne L Mcnees, 2002, Virus research.

Immune evasion by adenoviruses

L. Gooding, J. Mahr, 1999, Immunological reviews.

The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor

P. Duerksen-Hughes, T. Horton, T. Ranheim, 1991, Journal of virology.

The Adenovirus E3 Promoter Is Sensitive to Activation Signals in Human T Cells

L. Gooding, J. Boss, J. Mahr, 2003, Journal of Virology.

The Adenovirus E 3 Promoter Is Sensitive to Activation Signals in Human T Cells

L. Gooding, J. Boss, J. Mahr, 2002 .

Measurement of Tumor Necrosis Factor (TNF) Lysis of Adenovirus-Infected Cells

L. Gooding, J. Shisler, 1999 .

Adenoviral inhibitors of the apoptotic cascade.

L. Gooding, J. Shisler, 1998, Trends in microbiology.

The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model

R. Tripp, W. Wold, L. Gooding, 1996, Journal of virology.

Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis

T. Hermiston, P. Duerksen-Hughes, W. Wold, 1996, Journal of virology.

Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K.

W. Wold, L. Gooding, A. Tollefson, 1989, Journal of immunology.

Epigenetics and the dynamics of chromatin during adenovirus infections

L. Gooding, C. Garnett-Benson, D. Ornelles, 2019, FEBS letters.

Postinternalization Inhibition of Adenovirus Gene Expression and Infectious Virus Production in Human T-Cell Lines

L. Gooding, D. Ornelles, A. McNees, 2004, Journal of Virology.

Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein

S. Friend, E. Major, J. Pipas, 1990, Journal of virology.

Neonatal Infection with Species C Adenoviruses Confirmed in Viable Cord Blood Lymphocytes

L. Gooding, C. Garnett-Benson, D. Ornelles, 2015, PloS one.

Intestinal intussusception associated with adenovirus infection in Mexican children.

J. Guarner, J. Dawson, W. Shieh, 2003, American journal of clinical pathology.

Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.

L. Gooding, S. Chapes, 1985, Journal of immunology.

Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts.

L. Gooding, J. Boss, S. Laster, 1991, Immunology.

CELL SURFACE ANTIGENS OF A MOUSE TESTICULAR TERATOMA

M. Edidin, L. Gooding, Linda R. Gooding, 1974, The Journal of experimental medicine.

Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor

T. Horton, T. Ranheim, W. Wold, 1993, Journal of virology.

Susceptibility of anti-H-2-capped target cells to humoral and T lymphocyte-mediated lysis.

R. D. Stulting, L. Gooding, R. Todd, 1976, Transplantation.

Formation of SV40 specific and H–2 restricted target cell antigen by somatic cell fusion

L. Gooding, T. S. Watt, 1980, Nature.

Evidence that a target-derived soluble factor is necessary for the selective lysis of SV40-transformed fibroblasts by activated mouse macrophages.

L. Gooding, S. Laster, 1990, Journal of immunology.

Suppression of MHC class I antigen presentation by human adenoviruses.

L. Gooding, T. Sparer, 1998, Current topics in microbiology and immunology.

Macrophage-resistant murine simian virus 40 tumors express a retroviral type-specific gp70

L. Gooding, S. Chapes, L. Flaherty, 1987, Journal of virology.

Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40-transformed cells by activated macrophages.

P. Duerksen-Hughes, L. Aquino, L. Gooding, 1992, Journal of immunology.

Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: cross-reactivity of the H-2Kbm1 through Kbm4 H-2 mutant alleles in Kb-restricted SV40-specific killing.

A. Whitmore, L. Gooding, 1981, Journal of immunology.

Anomalous behavior of H-2Kb in immunity to syngeneic SV40 transformed cells: evidence for cytotoxic T cell recognition of H-2/SV40 membrane antigen complexes.

L. Gooding, 1980, Journal of immunology.

Regulation of TNF-mediated cell death and inflammation by human adenoviruses.

L. Gooding, 1994, Infectious agents and disease.

Formation, release, and identification of peptidyl-3(H)puromycins from wheat leaf ribosomes in vitro.

A. Jagendorf, L. Gooding, H. Roy, 1973, Archives of biochemistry and biophysics.

Analysis of a defect in the H-2 genes of SV40 transformed C3H fibroblasts that do not express H-2Kk.

G. Evans, D. Margulies, L. Gooding, 1983, Journal of immunology.

Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact-dependent.

L. Gooding, N. Zachariades, D. Day, 1994, Cellular Immunology.

Platelet-derived growth factor stimulates phagocytosis and blocks agonist-induced activation of the neutrophil oxidative burst: a possible cellular mechanism to protect against oxygen radical damage.

J. Lambeth, L. Gooding, E. Wilson, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Modeling Adenovirus Latency in Human Lymphocyte Cell Lines

L. Gooding, D. Ornelles, Yange Zhang, 2010, Journal of Virology.

Latent Species C Adenoviruses in Human Tonsil Tissues

L. Gooding, G. Talekar, D. Ornelles, 2008, Journal of Virology.